{"content":"<li class=\"n-box-item date-title\" data-end=\"1502423999\" data-start=\"1502337600\" data-txt=\"Monday, December 23, 2019\">Thursday, August 10, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3288513\" data-ts=\"1502423626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288513-aeterna-zentaris-beats-0_20-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AEterna Zentaris beats by $0.20, beats on revenue</a></h4><ul><li>AEterna Zentaris (NASDAQ:<a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a>): Q2 EPS of -$0.18 <font color='green'>beats by $0.20</font>.</li><li>Revenue of $0.24M (+140.0% Y/Y) <font color='green'>beats by $0.02M</font>.</li><li>Shares <font color='green'>+4.1%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16913549-aeterna-zentaris-reports-second-quarter-2017-financial-operating-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288513\" data-linked=\"AEterna Zentaris beats by $0.20, beats on revenue\" data-tweet=\"$AEZS - AEterna Zentaris beats by $0.20, beats on revenue https://seekingalpha.com/news/3288513-aeterna-zentaris-beats-0_20-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288513-aeterna-zentaris-beats-0_20-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288506\" data-ts=\"1502408723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUDA\" target=\"_blank\">CUDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288506-barracuda-networksplus-3_7-on-move-to-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barracuda Networks +3.7% on move to SmallCap 600</a></h4><ul>   <li>Barracuda Networks (<a href=\"http://seekingalpha.com/symbol/CUDA\" target=\"_blank\">CUDA</a> <font color='red'>-3.4%</font>) is <font color='green'>up 3.7%</font> after hours after news that it's <a href=\"https://seekingalpha.com/pr/16913584-sabra-health-care-reit-set-join-s-and-p-midcap-400-barracuda-networks-join-s-and-p-smallcap\" target=\"_blank\">joining the S&amp;P SmallCap 600</a>.</li>    <li>The firm is replacing Sabra Health Care REIT (<a href=\"http://seekingalpha.com/symbol/SBRA\" target=\"_blank\">SBRA</a> <font color='red'>-1.2%</font>) in the index prior to the open on Aug. 17.</li>    <li>Sabra is acquiring Care Capital Properties (<a href=\"http://seekingalpha.com/symbol/CCP\" target=\"_blank\">CCP</a> <font color='red'>-1.2%</font>) in a deal closing soon; Sabra will replace CCP in the MidCap 400, as the combined company will fit better there.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288506\" data-linked=\"Barracuda Networks +3.7% on move to SmallCap 600\" data-tweet=\"$CUDA $CUDA $SBRA - Barracuda Networks +3.7% on move to SmallCap 600 https://seekingalpha.com/news/3288506-barracuda-networksplus-3_7-on-move-to-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3288506-barracuda-networksplus-3_7-on-move-to-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288501\" data-ts=\"1502405199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMX\" target=\"_blank\">AMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288501-mexican-justice-sides-america-movil-on-rates-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mexican justice sides with America Movil on rates case</a></h4><ul>   <li>One of the justices on Mexico's Supreme Court has given a <a href=\"https://www.reuters.com/article/us-snap-results-idUSKBN1AQ2FO\" target=\"_blank\">vote of confidence to America Movil</a> (<a href=\"http://seekingalpha.com/symbol/AMX\" target=\"_blank\">AMX</a> <font color='green'>+2%</font>), saying he agrees with the company that interconnection rates belong in the purview of the country's telecoms regulator.</li>    <li>That doesn't settle the issue, which still faces a full court panel as soon as next week.</li>    <li>Telecom reform designed to counter America Movil's dominance barred the company from charging other carriers for calls made to customers on its network, though other companies bill America Movil for the practice.</li>    <li>Minister Javier Laynek Potisek agrees with the company that regulator IFT should set those rates, but also that competitors shouldn't have to reimburse America Movil for sizable past fees.</li>    <li>A victory for America Movil could have strong implications for rival giants in the market, AT&amp;T Mexico (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-0.4%</font>) and Telefonica (<a href=\"http://seekingalpha.com/symbol/TEF\" target=\"_blank\">TEF</a> <font color='red'>-2.2%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288501\" data-linked=\"Mexican justice sides with America Movil on rates case\" data-tweet=\"$AMX $AMX $T - Mexican justice sides with America Movil on rates case https://seekingalpha.com/news/3288501-mexican-justice-sides-america-movil-on-rates-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3288501-mexican-justice-sides-america-movil-on-rates-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288497\" data-ts=\"1502402833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288497-turtle-beach-shares-up-9-after-earnings-beat-full-year-guidance-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach shares up 9% after earnings beat, full year guidance increase</a></h4><ul><li>        Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) trades&nbsp;<font color='green'>up nearly 9%</font>&nbsp;aftermarket after the company reports Q2 results with an EPS and revenue beat with an increased full year guidance.</li><li>               The gaming headset and audio accessory company blamed the quarter&rsquo;s nearly 35% sales drop on a lingering impact from higher holiday inventory.&nbsp;</li><li>               Financials: gross margin, 33% (last year: 17.4%); headset segment gross margin, 33.3% (last year: 24.5%) operating expenses, $11.3M (last year: $45.6M); adjusted EBITDA, -$2.8M (-last year: $6.3M); cash and equivalents, $1.2M; outstanding debt, $39.7M.&nbsp;</li><li>               Q3 guidance: revenue, $36M to $40M (consensus: $40.17M); adjusted EBITDA, $1M; diluted net loss per share, $0.10 (consensus: $0.09).&nbsp;</li><li>               Full year guidance increased: revenue, $157M to $162M (consensus: $157.77M; former: $155M to $160M); adjusted EBITDA, $11M to $13M (former: $10M to $12M); diluted net loss per share, $0.06 to $0.10 (consensus: $0.11; former: $0.08 to $0.12).&nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16913329-turtle-beach-reports-second-quarter-2017-results-exceeding-outlook-raises-full-year-guidance\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288382-turtle-beach-beats-0_04-beats-revenue\" target=\"_blank\">Turtle Beach beats by $0.04, beats on revenue</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288497\" data-linked=\"Turtle Beach shares up 9% after earnings beat, full year guidance increase\" data-tweet=\"$HEAR - Turtle Beach shares up 9% after earnings beat, full year guidance increase https://seekingalpha.com/news/3288497-turtle-beach-shares-up-9-after-earnings-beat-full-year-guidance-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3288497-turtle-beach-shares-up-9-after-earnings-beat-full-year-guidance-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288490\" data-ts=\"1502401614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288490-nvidia-sharesminus-7_5-after-q2-guidance-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia shares -7.5% after Q2, guidance beats</a></h4><ul><li>        Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) shares&nbsp;<font color='red'>drop 7%</font>&nbsp;despite reporting Q2 EPS and revenue beats with record sales up 56% on the year. Q3 guidance revenue midpoint of $2.35B beat the consensus of $2.13B.&nbsp;</li><li>        Revenue by reportable segment: GPU, $1.9B (+ 59% Y/Y) and Tegra Processor, $333M (+101%).</li><li>               Revenue by Market Platform: Gaming, $1.2B (+52%); Professional Visualization, $235M (+10%); Datacenter, $416M (+175%); Automotive, $142M (+19%); OEM and IP, $251M (+54%).&nbsp;</li><li>               Financials: Non-GAAP gross margin, 58.6% (+50 bps); operating expenses, $533M (+19%); cash and equivalents, $5.9B; convertible debt, $84M.&nbsp;</li><li>               Capital return: Nvidia paid $758M in share repurchases and $166M in cash dividends in the first half of FY18; company plans to return $1.25B total this fiscal year.&nbsp;</li><li>Additional Q3 guidance: gross margin, within 50 bps of 58.8%; operating expenses, $570M; capital expenditures, $65M to $75M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16913411-nvidia-announces-financial-results-second-quarter-fiscal-2018\" target=\"_blank\">Press release</a> / <a href=\"http://files.shareholder.com/downloads/AMDA-1XAJD4/4965203459x0x953562/41D4959B-3296-4165-9D40-69471AD8AC78/Q2FY18_CFO_Commentary_FINAL.pdf\" target=\"_blank\">CFO commentary</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288404-nvidia-beats-0_31-beats-revenue\" target=\"_blank\">Nvidia beats by $0.31, beats on revenue</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288490\" data-linked=\"Nvidia shares -7.5% after Q2, guidance beats\" data-tweet=\"$NVDA - Nvidia shares -7.5% after Q2, guidance beats https://seekingalpha.com/news/3288490-nvidia-sharesminus-7_5-after-q2-guidance-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3288490-nvidia-sharesminus-7_5-after-q2-guidance-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>92&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288484\" data-ts=\"1502401181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288484-nordstromplus-3-q2-store-sales-growth-beats-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom +3% as Q2 same-store sales growth beats estimates</a></h4><ul>     <li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>)&nbsp;<font color='green'>+3.2%</font>&nbsp;AH after reporting generally in-line <a href=\"https://seekingalpha.com/news/3288358-nordstrom-beats-0_01-beats-revenue\" target=\"_blank\">Q2 earnings</a> and revenues but a <a href=\"https://www.bloomberg.com/news/articles/2017-08-10/nordstrom-gains-after-surprise-sales-growth-reassures-investors\" target=\"_blank\">surprise 1.7% same-store sales gain</a> that came in well ahead of the 0.5% decline forecast by analysts.</li>     <li>JWN says results were helped by a better than usual performance from its Anniversary Sale, historically the company's largest event of the year, as well as a strong showing from its private brands.</li>     <li>JWN upwardly revises guidance for FY 2017 sales growth, now expecting sales at the high end of its previous 3%-4% range; it sees EPS of $2.85-$3.00, up from $2.75-$3.00 previously, although the EPS range remains below the $3.01 analyst consensus estimate, and continues to forecast flat same-store sales.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288484\" data-linked=\"Nordstrom +3% as Q2 same-store sales growth beats estimates\" data-tweet=\"$JWN - Nordstrom +3% as Q2 same-store sales growth beats estimates https://seekingalpha.com/news/3288484-nordstromplus-3-q2-store-sales-growth-beats-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3288484-nordstromplus-3-q2-store-sales-growth-beats-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288482\" data-ts=\"1502401035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288482-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='green'>+10.4%</font>. <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='green'>+8.6%</font>. <a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='green'>+6.7%</font>. <a href='https://seekingalpha.com/symbol/PCTY' title='Paylocity Holding Corp'>PCTY</a> <font color='green'>+6.2%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+4.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/UNXL' title='Uni-Pixel, Inc.'>UNXL</a> <font color='red'>-23.4%</font>. <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='red'>-13.9%</font>. <a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-6.1%</font>. <a href='https://seekingalpha.com/symbol/UMC' title='United Microelectronics Corporation'>UMC</a> <font color='red'>-4.0%</font>. [[xiv]] <font color='red'>-4.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288482\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AMRS $TTD $BW - After Hours Gainers / Losers https://seekingalpha.com/news/3288482-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3288482-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288473\" data-ts=\"1502400014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPHS\" target=\"_blank\">SPHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288473-sophiris-bio-beats-0_11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sophiris Bio beats by $0.11</a></h4><ul><li>Sophiris Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a>): Q2 EPS of $0.02 <font color='green'>beats by $0.11</font>.</li><li>Shares <font color='green'>+3.63%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/16913500-sophiris-bio-reports-second-quarter-financial-results-key-corporate-highlights\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288473\" data-linked=\"Sophiris Bio beats by $0.11\" data-tweet=\"$SPHS - Sophiris Bio beats by $0.11 https://seekingalpha.com/news/3288473-sophiris-bio-beats-0_11?source=tweet\" data-url=\"https://seekingalpha.com/news/3288473-sophiris-bio-beats-0_11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288469\" data-ts=\"1502399772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288469-unipixel-down-23_5-after-q2-misses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniPixel down 23.5% after Q2 misses</a></h4><ul><li>        Uni-Pixel (NASDAQ:<a href='https://seekingalpha.com/symbol/UNXL' title='Uni-Pixel, Inc.'>UNXL</a>) shares are&nbsp;<font color='red'>down 23.5%</font>&nbsp;aftermarket to $0.26 as the company misses Q2 EPS and revenue estimates despite a year-over-year sales growth of over 38%.</li><li>               The touchscreen and flexible electronics company reported an operating loss of $9.9M and ended the quarter with $2.3M in cash and equivalents.&nbsp;</li><li>               Other key metrics: SG&amp;A, $2.6M (up from $1.9M) ; R&amp;D, $3M (up from $1M) ; adjusted EBITDA, -$8.1M (compared to -$4.2M).&nbsp;</li><li>               CEO Jeff Hawthorne notes that a XTouch sensor customer delayed taking delivery &ldquo;due to an LCD shortage and a battery issue which impacted their supply chain and ability to ship product&rdquo; and this had a significant impact on revenue. Deliveries expected to complete in upcoming quarters.&nbsp;</li><li>               Hawthorne also says the company increased the pricing on some XTouch sensors in the quarter with the changes effective in Q3.&nbsp;</li><li>               On August 8, the company announced a non-binding letter of intent for a strategic transaction allowing Future Tech to produce XTouch sensors in China. Future Tech will pay up to $5.1M for rights with $2M paid at initial closing and will separately cover all funding for establishing the manufacturing facilities. Agreement execution expected in September.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16913313-unipixel-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288349-uni-pixel-misses-0_10-misses-revenue\" target=\"_blank\">Uni-Pixel misses by $0.10, misses on revenue</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288469\" data-linked=\"UniPixel down 23.5% after Q2 misses\" data-tweet=\"$UNXL - UniPixel down 23.5% after Q2 misses https://seekingalpha.com/news/3288469-unipixel-down-23_5-after-q2-misses?source=tweet\" data-url=\"https://seekingalpha.com/news/3288469-unipixel-down-23_5-after-q2-misses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288451\" data-ts=\"1502398661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWS\" target=\"_blank\">NWS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288451-real-estate-highlights-news-corp-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Real estate highlights News Corp. report</a></h4><ul>   <li>News Corp. (<a href='https://seekingalpha.com/symbol/NWS' title='News Corporation'>NWS</a> <font color='red'>-3.8%</font>, <a href='https://seekingalpha.com/symbol/NWSA' title='News Corporation'>NWSA</a> <font color='red'>-3.5%</font>) is flat in heavy postmarket trading after the company posted <a href=\"https://seekingalpha.com/news/3288411-news-beats-0_01-misses-revenue\" target=\"_blank\">fiscal Q4 earnings</a> where it beat profit expectations but saw revenue decline everywhere but in real estate services.</li>    <li>Revenues fell for the quarter (-6.7%) and the fiscal year (-1.8%), but Q4 profits beat the Street.</li>    <li>Loss from continuing operations hit $424M, vs. a year-ago gain of $114M, mainly due to a $464M charge tied to a write-down of fixed assets at UK newspapers.</li>    <li>Real estate was again a bright spot, proving the only segment that grew revenues from the prior year.</li>    <li>Total Segment EBITDA in Q4 was $215M, down 40% Y/Y.</li>    <li>Revenue by segment: News and information services, $1.28B (down 10%); Book publishing, $407M (down 6%); Digital real estate services, $251M (up 10%); Cable network programming, $140M (down 5%).</li>    <li>EBITDA by segment: News and information services, $103M (down 36%); Book publishing, $39M (down 22%); Digital real estate services, $87M (down 50%); Cable network programming, $24M (up 4%).</li>    <li><a href=\"http://investors.newscorp.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16913397-news-corporation-reports-fourth-quarter-full-year-results-fiscal-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3288451\" data-linked=\"Real estate highlights News Corp. report\" data-tweet=\"$NWS $NWS $NWSA - Real estate highlights News Corp. report https://seekingalpha.com/news/3288451-real-estate-highlights-news-corp-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3288451-real-estate-highlights-news-corp-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288449\" data-ts=\"1502398523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288449-feds-looking-pfizers-greenstone-generics-business-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Feds looking into Pfizer&#39;s Greenstone generics business; shares down 1% after hours</a></h4><ul><li>Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) discloses in its Q2 report (<a href=\"https://www.sec.gov/ix?doc=/Archives/edgar/data/78003/000007800317000039/pfe-07022017x10q.htm\" target=\"_blank\">page 37</a>) that the U.S. Department of Justice's Antitrust Division is investigating its Greenstone generics unit, acquired in April 2003 as part of the Pharmacia transaction. The company says it believes that the inquiry relates to the government's ongoing antitrust investigation into the generic pharmaceuticals industry.</li><li>Shares are off&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288449\" data-linked=\"Feds looking into Pfizer&#39;s Greenstone generics business; shares down 1% after hours\" data-tweet=\"$PFE - Feds looking into Pfizer&#39;s Greenstone generics business; shares down 1% after hours https://seekingalpha.com/news/3288449-feds-looking-pfizers-greenstone-generics-business-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3288449-feds-looking-pfizers-greenstone-generics-business-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288437\" data-ts=\"1502397843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288437-fda-wants-long-term-safety-data-on-therapeuticsmds-txminus-004hr-meeting-set-for-november-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA wants long-term safety data on TherapeuticsMD&#39;s TX-004HR, meeting set for November 3 to determine if data sufficient to resolve CRL; shares down 7% after hours</a></h4><ul><li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) is down&nbsp;<font color='red'>7%</font>&nbsp;after hours on average volume in response to its <a href=\"https://seekingalpha.com/pr/16913352-therapeuticsmd-provides-txminus-004hr-regulatory-update\" target=\"_blank\">announced timeline</a> for (hopefully) resolving the CRL it received in May related to its marketing application seeking approval for TX-004HR (estradiol vaginal softgel capsule) for the treatment of women with moderate-to-severe vaginal pain during intercourse (dyspareunia). The CRL cited the need for long-term safety data beyond the 12 weeks in the REJOICE study.</li><li>The company submitted additional safety data to the agency on July 5. It recently received a letter from the review team saying the initial review was completed and requested the information be submitted to the NDA on or before September 18, including the safety data from the large observational study of long-term real-world users of vaginal estrogens (study is pending publication).</li><li>The FDA says its needs ~six weeks to review the data and has requested a November 3 meeting to discuss the outcome of the review. If the data are sufficient to address the CRL, the company plans to promptly refile the NDA.</li><li>Management will host a conference call at 5:00 pm ET to discuss the situation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3278873-therapeuticsmd-submits-crl-related-data-fda-review-timeline-undetermined-shares-7-percent\" target=\"_blank\">TherapeuticsMD submits CRL-related data to FDA, review timeline undetermined; shares down 7% premarket</a> (July 17)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264533-therapeuticsmds-vaginal-pain-drug-rejected-fda\" target=\"_blank\">TherapeuticsMD's vaginal pain drug rejected by FDA</a> (May 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288437\" data-linked=\"FDA wants long-term safety data on TherapeuticsMD&#39;s TX-004HR, meeting set for November 3 to determine if data sufficient to resolve CRL; shares down 7% after hours\" data-tweet=\"$TXMD - FDA wants long-term safety data on TherapeuticsMD&#39;s TX-004HR, meeting set for November 3 to determine if data sufficient to resolve CRL; shares down 7% after hours https://seekingalpha.com/news/3288437-fda-wants-long-term-safety-data-on-therapeuticsmds-txminus-004hr-meeting-set-for-november-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3288437-fda-wants-long-term-safety-data-on-therapeuticsmds-txminus-004hr-meeting-set-for-november-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288412\" data-ts=\"1502396725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288412-trade-deskplus-8_3-on-heavy-q2-beat-raised-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Trade Desk +8.3% on heavy Q2 beat, raised guidance</a></h4><ul>   <li>The Trade Desk (<a href=\"http://seekingalpha.com/symbol/TTD\" target=\"_blank\">TTD</a> <font color='red'>-7.3%</font>) has <font color='green'>leapt 8.3%</font> after hours, erasing today's losses, after <a href=\"https://seekingalpha.com/news/3288344-trade-desk-beats-0_33-beats-revenue\" target=\"_blank\">Q2 earnings</a> beat on top and bottom lines and it boosted full-year expectations.</li>    <li>The company continues to \"see momentum as ad dollars shift to programmatic,\" leading it to expect higher revenues for the rest of the year.</li>    <li>Adjusted EBITDA of $25.3M was well ahead of expectations for $15.3M.</li>    <li>Without giving figures, it said native spend in Q2 surpassed all native spend for 2016 (launched in Q2 2016). Mobile In-App grew 87% Y/Y; Mobile Video was up 171%, and Connected TV up 167%.</li>    <li>Customer retention was over 95% for the 15th straight quarter, it notes.</li>    <li>It's guiding to Q3 revenues of $76M (above consensus for $74.1M) and EBITDA of $21M (vs. expected $21.2M).</li>    <li>For the full year it's raising revenue guidance to $303M from $291M (above consensus for $294.3M), and boosting EBITDA expectations to $88M from $78M (vs. an expected $79.8M).</li>    <li><a href=\"http://investors.thetradedesk.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m.</li>    <li><a href=\"https://seekingalpha.com/pr/16913308-trade-desk-reports-second-quarter-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3288412\" data-linked=\"The Trade Desk +8.3% on heavy Q2 beat, raised guidance\" data-tweet=\"$TTD - The Trade Desk +8.3% on heavy Q2 beat, raised guidance https://seekingalpha.com/news/3288412-trade-deskplus-8_3-on-heavy-q2-beat-raised-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3288412-trade-deskplus-8_3-on-heavy-q2-beat-raised-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288404\" data-ts=\"1502396469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288404-nvidia-beats-0_31-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia beats by $0.31, beats on revenue</a></h4><ul><li>Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>): Q2 EPS of $1.01 <font color='green'>beats by $0.31</font>.</li><li>Revenue of $2.23B (+55.9% Y/Y) <font color='green'>beats by $270M</font>.</li><li>Shares <font color='green'>+2.4%</font>.</li><li><a href='https://seekingalpha.com/pr/16913411-nvidia-announces-financial-results-second-quarter-fiscal-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288404\" data-linked=\"Nvidia beats by $0.31, beats on revenue\" data-tweet=\"$NVDA - Nvidia beats by $0.31, beats on revenue https://seekingalpha.com/news/3288404-nvidia-beats-0_31-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288404-nvidia-beats-0_31-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>229&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288395\" data-ts=\"1502396255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDNA\" target=\"_blank\">CDNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288395-caredx-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CareDx beats by $0.02, beats on revenue</a></h4><ul><li>CareDx (NASDAQ:<a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a>): Q2 EPS of -$0.17 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $12.05M (+12.2% Y/Y) <font color='green'>beats by $0.25M</font>.</li><li>Shares <font color='green'>+13.26%</font>.</li><li><a href='https://seekingalpha.com/pr/16913302-caredx-reports-second-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288395\" data-linked=\"CareDx beats by $0.02, beats on revenue\" data-tweet=\"$CDNA - CareDx beats by $0.02, beats on revenue https://seekingalpha.com/news/3288395-caredx-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288395-caredx-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288392\" data-ts=\"1502396209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288392-snapminus-6-q2-loss-revenues-disappoint-street-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap -6% as Q2 loss, revenues disappoint Street (updated)</a></h4><ul>     <li>Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='green'>+1%</font>) has <font color='red'>tumbled 6%</font> in volatile trade after hours after its <a href=\"https://seekingalpha.com/news/3288372-snap-misses-0_02-misses-revenue\" target=\"_blank\">Q2 report</a> came up short of expectations on top and bottom lines</li>     <li>Net loss widened to $443.1M from a year-ago $115.9M. Revenues rose 153% to $181.7M, short of expectations for $186.5M.</li>     <li>EBITDA came to -$194M vs. an expected -$185.4M.</li>     <li>Operational metrics looked better than financials: Daily active users rose to a relatively healthy 173M from last year's 143M, up 21% Y/Y and up 7.3M (4%) from the previous quarter.</li>     <li>Average revenue per user came in at $1.05, over the psychological barrier of $1.00 and more than double a year ago ($0.50). It rose 16% Q/Q from Q1's $0.90.</li>     <li>Capex was $19.4M vs. a year-ago $16.4M.</li>     <li>Free cash flow was -$228.94M. Cash, equivalents and marketable securities stood at $2.8B.</li>     <li><b>Updated 4:38 p.m.:</b> <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> is now <font color='red'>off 14.1%</font>, quoting at $11.83 vs. its IPO price of $17.</li>     <li><a href=\"http://investor.snap.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>     <li><a href=\"https://seekingalpha.com/pr/16913372-snap-inc-reports-second-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3288392\" data-linked=\"Snap -6% as Q2 loss, revenues disappoint Street (updated)\" data-tweet=\"$SNAP - Snap -6% as Q2 loss, revenues disappoint Street (updated) https://seekingalpha.com/news/3288392-snapminus-6-q2-loss-revenues-disappoint-street-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3288392-snapminus-6-q2-loss-revenues-disappoint-street-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288388\" data-ts=\"1502396163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWH\" target=\"_blank\">CWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288388-camping-world-beats-0_23-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camping World beats by $0.23, beats on revenue</a></h4><ul><li>Camping World (NYSE:<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a>): Q2 EPS of $0.91 <font color='green'>beats by $0.23</font>.</li><li>Revenue of $1.28B (+19.6% Y/Y) <font color='green'>beats by $110M</font>.</li><li>Shares <font color='green'>+5.82%</font>.</li><li><a href='https://seekingalpha.com/pr/16913343-camping-world-holdings-inc-announces-second-quarter-fiscal-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288388\" data-linked=\"Camping World beats by $0.23, beats on revenue\" data-tweet=\"$CWH - Camping World beats by $0.23, beats on revenue https://seekingalpha.com/news/3288388-camping-world-beats-0_23-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288388-camping-world-beats-0_23-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288383\" data-ts=\"1502396053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288383-amyris-beats-0_60-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris beats by $0.60, beats on revenue</a></h4><ul><li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>): Q2 GAAP EPS of -$0.46 <font color='green'>beats by $0.60</font>; Non-GAAP EPS&nbsp;of -$1.36.</li><li>Revenue of $25.7M (+167.7% Y/Y) <font color='green'>beats by $2M</font>.</li><li>Shares <font color='green'>+15.6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16913310-amyris-delivers-another-strong-quarter-revenue-25_7-million-product-sales-increase-159\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288383\" data-linked=\"Amyris beats by $0.60, beats on revenue\" data-tweet=\"$AMRS - Amyris beats by $0.60, beats on revenue https://seekingalpha.com/news/3288383-amyris-beats-0_60-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288383-amyris-beats-0_60-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288379\" data-ts=\"1502396023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAPR\" target=\"_blank\">CAPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288379-capricor-therapeutics-beats-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capricor Therapeutics beats by $0.02, misses on revenue</a></h4><ul><li>Capricor Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a>): Q2 EPS of -$0.16 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $0.99M (-12.4% Y/Y) <font color='red'>misses by $0.11M</font>.</li><li>Shares <font color='green'>+7.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16913321-capricor-therapeutics-reports-second-quarter-2017-financial-results-provides-corporate-update'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288379\" data-linked=\"Capricor Therapeutics beats by $0.02, misses on revenue\" data-tweet=\"$CAPR - Capricor Therapeutics beats by $0.02, misses on revenue https://seekingalpha.com/news/3288379-capricor-therapeutics-beats-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288379-capricor-therapeutics-beats-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288358\" data-ts=\"1502395663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288358-nordstrom-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom beats by $0.01, beats on revenue</a></h4><ul><li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>): Q2 EPS of $0.65 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $3.79B (+3.8% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+6.42%</font>.</li><li><a href='https://seekingalpha.com/pr/16913337-nordstrom-second-quarter-2017-earnings-achieved-expectations'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288358\" data-linked=\"Nordstrom beats by $0.01, beats on revenue\" data-tweet=\"$JWN - Nordstrom beats by $0.01, beats on revenue https://seekingalpha.com/news/3288358-nordstrom-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288358-nordstrom-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288337\" data-ts=\"1502394596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYV\" target=\"_blank\">LYV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288337-live-nation-sheds-earnings-gains-on-report-of-amazon-ticketing-service-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Nation sheds earnings gains on report of Amazon ticketing service plan</a></h4><ul>   <li>After <font color='green'>vaulting as much as 12.5%</font> today to a 52-week high after a robust <a href=\"https://seekingalpha.com/news/3288180-solid-earnings-beat-drives-live-nation-plus-8_5-percent-premarket\" target=\"_blank\">earnings report</a>, Live Nation Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/LYV' title='Live Nation Entertainment, Inc.'>LYV</a>) has shed the bulk of the gains, <font color='green'>now up just 1.3%</font>, after Reuters reports Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color='red'>-2.6%</font>) is looking to partner with venues on <a href=\"https://www.reuters.com/article/us-amazon-com-ticketing-idUSKBN1AQ2DB?il=0\" target=\"_blank\">offering its own event ticketing</a>.</li>    <li>Such a move could shake the firm grip that Live Nation's Ticketmaster has on the business.</li>    <li>Amazon sees the market as ripe for attack, Reuters says, with unrest from not only consumers but also venue owners, sports leagues and teams.</li><li>Amazon's had conversations about partnering with Ticketmaster, but those talks reportedly stalled over who would control customers' data, sources told Reuters.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288337\" data-linked=\"Live Nation sheds earnings gains on report of Amazon ticketing service plan\" data-tweet=\"$LYV $LYV $AMZN - Live Nation sheds earnings gains on report of Amazon ticketing service plan https://seekingalpha.com/news/3288337-live-nation-sheds-earnings-gains-on-report-of-amazon-ticketing-service-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3288337-live-nation-sheds-earnings-gains-on-report-of-amazon-ticketing-service-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288336\" data-ts=\"1502394395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAAS\" target=\"_blank\">PAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288336-pan-american-silverplus-11-after-strong-q2-beat-reduced-cost-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pan American Silver +11% after strong Q2 beat, reduced cost guidance</a></h4><ul>     <li>Pan American Silver (<a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a> <font color='green'>+11.6%</font>) maintains strong gains following its easy <a href=\"https://seekingalpha.com/news/3287854-pan-american-silver-beats-0_05-beats-revenue\" target=\"_blank\">Q2 earnings</a> beat, which it attributes to higher commodity prices and lower selling costs even as Q2 silver production of 6.3M oz. was flat Y/Y and gold production fell 22% to 37.7K oz.</li><li>PAAS says silver production for H1 totaled 12.5M oz., meaning the company is on track to achieve its full-year targeted range  of 24.5M-26M oz., and H1 gold production was 75.4K oz.; given higher anticipated production for the rest of the year at the Dolores mine in Mexico, PAAS reaffirms its FY 2017 gold production guidance of 155K-165K oz.</li>          <li>PAAS also says Q2 all-in sustaining costs per silver oz. sold fell 5% to $10.73 from $11.31 at this time last year; these factors as well as better than expected progress on the mine expansion program prompt the company to lower its estimate for full-year all-in sustaining costs by ~10% to $10.50-$11.50 from $11.50-$12.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288336\" data-linked=\"Pan American Silver +11% after strong Q2 beat, reduced cost guidance\" data-tweet=\"$PAAS - Pan American Silver +11% after strong Q2 beat, reduced cost guidance https://seekingalpha.com/news/3288336-pan-american-silverplus-11-after-strong-q2-beat-reduced-cost-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3288336-pan-american-silverplus-11-after-strong-q2-beat-reduced-cost-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288335\" data-ts=\"1502394240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288335-live-venturesminus-4_4-after-fiscal-q3-release\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures -4.4% after fiscal Q3 release</a></h4><ul>   <li>Live Ventures (NASDAQ:<a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a>) is <font color='red'>off 4.4%</font> after <a href=\"https://www.sec.gov/Archives/edgar/data/1045742/000168316817002027/liveventures_10q-063017.htm\" target=\"_blank\">posting the 10-Q filing</a> tied to its quarterly earnings announcement, which it summarized this morning.</li>    <li>Sales more than doubled to a record $41.4M, and gross profit more than tripled to $16.99M.</li>    <li>Net income tumbled Y/Y, though, as the prior year's net income was almost entirely made up of a $12.3M benefit for deferred tax expense. Income before provision for income taxes rose to $3.3M from $1.1M.</li>    <li>Revenue by segment: Retail and online, $19.3M (up 369%); Manufacturing, $21.9M (up 13.8%); Services, $210,889 (down 13.3%).</li>    <li>Cash flow from operations is at $8.8M YTD.</li>    <li><a href=\"www.live-ventures.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/news/3288114-live-ventures-reports-q3-results\" target=\"_blank\">Early fiscal Q3 results</a></li>    <li><a href=\"https://seekingalpha.com/pr/16912641-live-ventures-incorporated-announces-third-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3288335\" data-linked=\"Live Ventures -4.4% after fiscal Q3 release\" data-tweet=\"$LIVE - Live Ventures -4.4% after fiscal Q3 release https://seekingalpha.com/news/3288335-live-venturesminus-4_4-after-fiscal-q3-release?source=tweet\" data-url=\"https://seekingalpha.com/news/3288335-live-venturesminus-4_4-after-fiscal-q3-release\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288332\" data-ts=\"1502392878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288332-ringcentral-gives-back-m-fueled-gainsminus-3_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral gives back some M&amp;A-fueled gains, -3.4%</a></h4><ul>   <li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) <font color='green'>rose 10.4% </font>yesterday on word that it had hired an adviser to <a href=\"https://seekingalpha.com/news/3287632-ringcentral-hires-advisor-takeover-offers-shares-plus-8_8-percent\" target=\"_blank\">gauge takeover interest</a>; it's retrenching today, <font color='red'>down 3.4%</font>, as analysts weigh that news.</li>    <li>Baird has downgraded the company to Neutral from Outperform, saying risk/reward is now fair, and given it a $41 price target, implying 9.2% upside from today's lower price.</li>    <li>The firm's William Power thinks the company would draw $44/share as a takeout target, or even up to $50/share.</li>    <li>SunTrust, meanwhile, thinks RingCentral could draw a mid-50s price if it's seen as a productivity platform rather than a business phone system provider. The firm has a Buy rating and $47 price target on the fundamentals. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288332\" data-linked=\"RingCentral gives back some M&amp;A-fueled gains, -3.4%\" data-tweet=\"$RNG - RingCentral gives back some M&amp;A-fueled gains, -3.4% https://seekingalpha.com/news/3288332-ringcentral-gives-back-m-fueled-gainsminus-3_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3288332-ringcentral-gives-back-m-fueled-gainsminus-3_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288326\" data-ts=\"1502391613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288326-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LUNA' title='Luna Innovations Incorporated'>LUNA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SPRT' title='Support.com, Inc.'>SPRT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/EMAN' title='eMagin Corporation'>EMAN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies'>MRAM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288326\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$LUNA $SPRT $ASYS - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3288326-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3288326-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288318\" data-ts=\"1502390151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288318-wedbush-latest-to-back-foot-locker\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush latest to back Foot Locker</a></h4><ul>     <li>Wedbush is positive on Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-0.7%</font>) after talking to Nike management about the company's plan to sell directly on Amazon.com.</li>     <li>\"FL is still and will continue to be a strategic account and several of its retail concepts will play into NKE&rsquo;s direct strategy,\" notes analyst Christopher Svezia.</li><li>\"Furthermore, our 8/8 expert call gave us confidence that NKE&rsquo;s allocation model will still greatly favor FL over Amazon,\" he adds.</li><li>Wedbush trims its <a href=\"http://www.barrons.com/articles/foot-locker-nike-still-needs-it-1502380687\" target=\"_blank\">price target</a> to $66 from $72.</li><li>Shares of Foot Locker are down 30% YTD. A wave of analysts have pitched the case that Foot Locker is oversold.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269165-foot-locker-weakness-buying-opportunity-three-analysts-say\" target=\"_blank\">Foot Locker weakness a buying opportunity, three analysts say</a> (May 22)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286704-morgan-stanley-positive-foot-locker\" target=\"_blank\">Morgan Stanley positive on Foot Locker</a> (Aug. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288318\" data-linked=\"Wedbush latest to back Foot Locker\" data-tweet=\"$FL - Wedbush latest to back Foot Locker https://seekingalpha.com/news/3288318-wedbush-latest-to-back-foot-locker?source=tweet\" data-url=\"https://seekingalpha.com/news/3288318-wedbush-latest-to-back-foot-locker\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288317\" data-ts=\"1502390131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LILAB\" target=\"_blank\">LILAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288317-america-movilplus-1_9-morgan-stanley-likes-mexico-brazil-telecoms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">America Movil +1.9% as Morgan Stanley likes Mexico, Brazil telecoms</a></h4><ul>   <li>America Movil (<a href=\"http://seekingalpha.com/symbol/AMX\" target=\"_blank\">AMX</a> <font color='green'>+1.9%</font>) has moved up after an upgrade from Morgan Stanley, which is <a href=\"http://www.barrons.com/articles/mexicos-america-movil-upgraded-in-latam-telecom-turnaround-1502383946\" target=\"_blank\">favoring telecom markets in Mexico and Brazil</a> over those in Peru and Colombia.</li>    <li>\"A sequential macro recovery, and more accessible telco services, should boost the consumption of value added services (e.g. one more day of access to social media) or potential upgrade from prepaid to postpaid wireless,\" the firm says in a detailed report on Latin American telecom.</li>    <li>America Movil and Brazil's TIM Participa&ccedil;&otilde;es (<a href=\"http://seekingalpha.com/symbol/TSU\" target=\"_blank\">TSU</a> <font color='red'>-0.6%</font>) are its top picks in a rubric that ranged across companies' product, geography, and profitability measures. TIM gets the nod in Brazil over Telefonica Brasil (<a href=\"http://seekingalpha.com/symbol/VIV\" target=\"_blank\">VIV</a> <font color='red'>-1.2%</font>), rated at Equal Weight.</li>    <li>It's set a price target of $21 on AMX, implying 17.4% upside from today's higher price.</li>    <li>Meanwhile, Morgan Stanley downgraded Telecom Argentina (<a href=\"http://seekingalpha.com/symbol/TEO\" target=\"_blank\">TEO</a> <font color='red'>-1.6%</font>) and Grupo Televisa (<a href=\"http://seekingalpha.com/symbol/TV\" target=\"_blank\">TV</a> <font color='red'>-0.8%</font>) to Equal Weight, and Liberty Global LiLAC (<a href='https://seekingalpha.com/symbol/LILAB' title='Liberty Latin America Ltd.B'>OTC:LILAB</a>) to Underweight.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288317\" data-linked=\"America Movil +1.9% as Morgan Stanley likes Mexico, Brazil telecoms\" data-tweet=\"$LILAB $LILAB $AMX - America Movil +1.9% as Morgan Stanley likes Mexico, Brazil telecoms https://seekingalpha.com/news/3288317-america-movilplus-1_9-morgan-stanley-likes-mexico-brazil-telecoms?source=tweet\" data-url=\"https://seekingalpha.com/news/3288317-america-movilplus-1_9-morgan-stanley-likes-mexico-brazil-telecoms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288311\" data-ts=\"1502388050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288311-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NSU' title='Nevsun Resources Ltd.'>NSU</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288311\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$PFIE $PAAS $AMRS - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3288311-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3288311-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288308\" data-ts=\"1502387252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288308-retail-sector-slides-earnings-reports-throw-spotlight-on-weak-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail sector slides as earnings reports throw a spotlight on weak traffic</a></h4><ul><li>The SPDR S&amp;P Retail ETF(NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is&nbsp;<font color='red'>down 2.61%</font>&nbsp;as the sector takes its marching orders from a weak trio of earnings reports in the department store sector (KSS, DDS, M), guidance warnings and analyst caution.</li><li>The broad-based declines, centered on traffic and pricing concerns, cover a large number of well-known retailers -- including Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-3.8%</font>), Signet Jewelers (<a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a> <font color='red'>-6.9%</font>), Conn's (<a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a> <font color='red'>-6.6%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-3.3%</font>), Lands' End (<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a> <font color='red'>-5.1%</font>), Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-7.7%</font>), Sears Holdings (SHLD <font color='red'>-10.1%</font>), Big Lots (<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color='red'>-2.8%</font>), Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-4.2%</font>), American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='red'>-6.2%</font>) and Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-3.8%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLY' title='Consumer Discretionary Select Sector SPDR ETF'>XLY</a>, <a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>, <a href='https://seekingalpha.com/symbol/VCR' title='Vanguard Consumer Discretionary ETF'>VCR</a>, <a href='https://seekingalpha.com/symbol/RTH' title='VanEck Vectors Retail ETF'>RTH</a>, <a href='https://seekingalpha.com/symbol/RETL' title='Direxion Daily Retail Bull 3x Shares ETF'>RETL</a>, <a href='https://seekingalpha.com/symbol/FDIS' title='Fidelity MSCI Consumer Discretionary Index ETF'>FDIS</a>, <a href='https://seekingalpha.com/symbol/IYC' title='iShares U.S. Consumer Services ETF'>IYC</a>, <a href='https://seekingalpha.com/symbol/FXD' title='First Trust Consumer Discretionary AlphaDEX ETF'>FXD</a>, <a href='https://seekingalpha.com/symbol/SCC' title='ProShares UltraShort Consumer Services ETF'>SCC</a>, <a href='https://seekingalpha.com/symbol/UCC' title='ProShares Ultra Consumer Services ETF'>UCC</a>, <a href='https://seekingalpha.com/symbol/RCD' title='Invesco S&P Equal Weight Consumer Discretionary ETF'>RCD</a>, <a href='https://seekingalpha.com/symbol/PEZ' title='Invesco DWA Consumer Cyclicals Momentum Portfolio ETF'>PEZ</a>, <a href='https://seekingalpha.com/symbol/PMR' title='Invesco Dynamic Retail Portfolio ETF'>PMR</a>, <a href='https://seekingalpha.com/symbol/FTXD' title='First Trust Nasdaq Retail ETF'>FTXD</a>, <a href='https://seekingalpha.com/symbol/CNDF' title='iShares Edge MSCI Multifactor Consumer Discretionary ETF'>CNDF</a>, <a href='https://seekingalpha.com/symbol/JHMC' title='John Hancock Multifactor Consumer Discretionary ETF'>JHMC</a>, <a href='https://seekingalpha.com/symbol/XD' title='Elkhorn S&P MidCap Consumer Discretionary ETF'>XD</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288308\" data-linked=\"Retail sector slides as earnings reports throw a spotlight on weak traffic\" data-tweet=\"$TGT $XRT $TGT - Retail sector slides as earnings reports throw a spotlight on weak traffic https://seekingalpha.com/news/3288308-retail-sector-slides-earnings-reports-throw-spotlight-on-weak-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/3288308-retail-sector-slides-earnings-reports-throw-spotlight-on-weak-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288304\" data-ts=\"1502386653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288304-celgene-slips-3-on-modified-oncology-deal-sutro\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene slips 3% on modified oncology deal with Sutro</a></h4><ul><li>The market's down day notwithstanding, Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-2.8%</font>) retreats on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16912463-sutro-and-celgene-refocus-2014-immuno-oncology-collaboration-four-programs\" target=\"_blank\">revised immuno-oncology collaboration </a>with Sutro.</li><li>The partnership is focused on four programs, including an antibody-drug conjugate targeting B-cell maturation antigen &#40;BCMA&#41;. Under the original 2014 agreement, Celgene had global rights to the first program to reach IND status.</li><li>Under the revised agreement, it can acquire global rights to the second program to reach IND status by making unspecified payments to Sutro. For the next two programs, Sutro will retain exclusive U.S. rights while Celgene will retain exclusive ex-U.S. rights. Upon signing the revised deal, Sutro will receive an undisclosed payment and will continue to be entitled to development- and regulatory-based milestones and royalties.</li><li>Celgene has the right to purchase shares of Sutro stock in a future private financing and the right to purchase shares in a private placement concurrent with a Sutro IPO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2055355-celgene-ups-its-ante-with-sutro\" target=\"_blank\">Celgene ups its ante with Sutro</a> (Oct. 23, 2014)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288304\" data-linked=\"Celgene slips 3% on modified oncology deal with Sutro\" data-tweet=\"$CELG - Celgene slips 3% on modified oncology deal with Sutro https://seekingalpha.com/news/3288304-celgene-slips-3-on-modified-oncology-deal-sutro?source=tweet\" data-url=\"https://seekingalpha.com/news/3288304-celgene-slips-3-on-modified-oncology-deal-sutro\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288307\" data-ts=\"1502386432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288307-j-c-penney-slides-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney slides ahead of earnings</a></h4><ul><li>J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-6.7%</font>) heads into tomorrow's earnings day on a down note after peers Kohl's, Dillard's and Macy's all stumbled with their reports.</li><li>Hope that a wave of bankrupcties helped to add some incremental traffic at department stores faded after Dillard's and Macy's all reported weak same-store sales/</li><li>Analysts expect J.C. Penney to report sales of $2.84B and a $0.05 loss for the quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288307\" data-linked=\"J.C. Penney slides ahead of earnings\" data-tweet=\"$JCP - J.C. Penney slides ahead of earnings https://seekingalpha.com/news/3288307-j-c-penney-slides-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3288307-j-c-penney-slides-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288223\" data-ts=\"1502385204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288223-perrigo-q2-beat-lifts-generics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perrigo Q2 beat lifts generics</a></h4><ul><li>Battered and bruised investors in (most)&nbsp;generic drug makers are getting a welcome reprieve this morning after Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='green'>+18.9%</font>) posted better-than-expected Q2 results and raised its outlook for non-GAAP EPS.</li><li>Selected tickers: (VRX <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+1%</font>)(<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color='red'>-4.9%</font>)(<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='green'>+1.7%</font>)(<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-2.8%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287939-perrigo-beats-0_29-beats-revenue\" target=\"_blank\">Perrigo beats by $0.29, beats on revenue</a> (Aug. 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288038-perrigo-q2-top-line-8-percent-non-gaap-earnings-5-percent-cash-flow-24-percent-non-gaap-eps\" target=\"_blank\">Perrigo Q2 top line down 8%; non-GAAP earnings down 5%; cash flow up 24%; non-GAAP EPS guidance raised; shares up 11% premarket</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288223\" data-linked=\"Perrigo Q2 beat lifts generics\" data-tweet=\"$PRGO $PRGO $BHC - Perrigo Q2 beat lifts generics https://seekingalpha.com/news/3288223-perrigo-q2-beat-lifts-generics?source=tweet\" data-url=\"https://seekingalpha.com/news/3288223-perrigo-q2-beat-lifts-generics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288302\" data-ts=\"1502384784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APEN\" target=\"_blank\">APEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288302-apollo-endo-down-31-on-fda-report-of-deaths-in-patients-orbera-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Endo down 31% on FDA report of deaths in patients with Orbera System</a></h4><ul><li>Thinly traded nano cap Apollo Endosurgery (<a href='https://seekingalpha.com/symbol/APEN' title='Apollo Endosurgery'>APEN</a> <font color='red'>-30.7%</font>) slumps on double normal, albeit on turnover of only 84K shares, in response to an <a href=\"https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm570916.htm\" target=\"_blank\">FDA alert</a> concerning unexpected deaths in patients with liquid-filled intragastric balloon systems used to treat obesity.</li><li>A total of five deaths have been reported, four with Apollo's <a href=\"http://apolloendo.com/orbera/\" target=\"_blank\">Orbera Intragastric Balloon System</a> and one with ReShape Medical's <a href=\"https://reshapeready.com/weight-loss-balloons/\" target=\"_blank\">Reshape Integrated Dual Balloon System</a>. All deaths occurred within a month or less after receiving the product, three within one-to-three days after placement. The causes are unknown at present.</li><li>The FDA has received reports of two additional deaths in the same time period related to potential complications associated with balloon treatment, one gastric perforation with Orbera and one esophageal perforation with ReShape.</li><li>In February, the agency <a href=\"https://www.fda.gov/medicaldevices/resourcesforyou/healthcareproviders/ucm540655.htm\" target=\"_blank\">issued a letter</a> to healthcare providers recommending close monitoring of patients with liquid-filled intragastric balloon systems for acute pancreatitis and spontaneous over-inflation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288302\" data-linked=\"Apollo Endo down 31% on FDA report of deaths in patients with Orbera System\" data-tweet=\"$APEN - Apollo Endo down 31% on FDA report of deaths in patients with Orbera System https://seekingalpha.com/news/3288302-apollo-endo-down-31-on-fda-report-of-deaths-in-patients-orbera-system?source=tweet\" data-url=\"https://seekingalpha.com/news/3288302-apollo-endo-down-31-on-fda-report-of-deaths-in-patients-orbera-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288301\" data-ts=\"1502384741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288301-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AEG' title='AEGON NV'>AEG</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MLP' title='Maui Land & Pineapple Company, Inc.'>MLP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/HRTG' title='Heritage Insurance Holdings, Inc.'>HRTG</a> <font color='red'>-10%</font>. RAS <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288301\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$PMTS $AEG $MLP - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3288301-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3288301-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288295\" data-ts=\"1502383574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288295-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CYAN' title='Cyanotech Corporation'>CYAN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LUNA' title='Luna Innovations Incorporated'>LUNA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CHEF' title='Chefs&#39; Warehouse'>CHEF</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SPRT' title='Support.com, Inc.'>SPRT</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-65%</font>. <a href='https://seekingalpha.com/symbol/FRTA' title='Forterra'>FRTA</a> <font color='red'>-51%</font>. <a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/APEN' title='Apollo Endosurgery'>APEN</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/CYD' title='China Yuchai International Limited'>CYD</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/DOOR' title='Masonite International Corporation'>DOOR</a> <font color='red'>-23%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288295\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CYAN $HDSN $QHC - Midday Gainers / Losers https://seekingalpha.com/news/3288295-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3288295-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288282\" data-ts=\"1502382208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QHC\" target=\"_blank\">QHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288282-quorum-up-19-on-improved-execution-in-q2-non-gaap-ebitda-up-18-cash-flow-down-175\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quorum up 19% on improved execution in Q2, non-GAAP EBITDA up 18%, cash flow down 175%</a></h4><ul><li>Quorum Health (<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+19.3%</font>) heads north on 50% higher volume after it posted <a href=\"https://seekingalpha.com/pr/16912013-quorum-health-corporation-announces-second-quarter-2017-operating-results\" target=\"_blank\">Q2 results</a> that reflected improved operations.</li><li>Revenues: 530.1 (flat); Net Loss: (30.6) (+87.5%); EBITDA: 20.2 (+108.9%); Non-GAAP EBITDA: 34.4 (+17.8%); Loss/Share: (1.09) (+87.4%); CF Ops: (27.5) (-174.7%).</li><li><strong>2017 Guidance</strong>: Revenues: $2.05B - 2.10B; Non-GAAP EBITDA: $150M - 170M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288282\" data-linked=\"Quorum up 19% on improved execution in Q2, non-GAAP EBITDA up 18%, cash flow down 175%\" data-tweet=\"$QHC - Quorum up 19% on improved execution in Q2, non-GAAP EBITDA up 18%, cash flow down 175% https://seekingalpha.com/news/3288282-quorum-up-19-on-improved-execution-in-q2-non-gaap-ebitda-up-18-cash-flow-down-175?source=tweet\" data-url=\"https://seekingalpha.com/news/3288282-quorum-up-19-on-improved-execution-in-q2-non-gaap-ebitda-up-18-cash-flow-down-175\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288277\" data-ts=\"1502380857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288277-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MLR' title='Miller Industries Inc.'>MLR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288277\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$CELH $TIS $VSTO - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3288277-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3288277-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288275\" data-ts=\"1502380724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288275-wweplus-2_7-subscription-video-service-set-to-enter-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE +2.7% as subscription video service set to enter China</a></h4><ul>   <li>World Wrestling Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) is <font color='green'>up 2.7%</font> this morning following news that the <a href=\"https://seekingalpha.com/pr/16912742-pptv-wwe-launch-wwe-network-china\" target=\"_blank\">WWE Network is headed to China</a> in just over a week.</li>    <li>Working with PPTV, the subscription video-on-demand service will be available in China for the first time Aug. 18. That will make WWE's SummerSlam (set for Aug. 21 in Beijing) available live in Mandarin in time for the event.</li>    <li>Customers will be able to watch via smart TVs, set-top boxes and mobile devices as well as on the Web.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288275\" data-linked=\"WWE +2.7% as subscription video service set to enter China\" data-tweet=\"$WWE - WWE +2.7% as subscription video service set to enter China https://seekingalpha.com/news/3288275-wweplus-2_7-subscription-video-service-set-to-enter-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3288275-wweplus-2_7-subscription-video-service-set-to-enter-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288274\" data-ts=\"1502380591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288274-kura-oncology-launches-equity-offering-shares-down-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura Oncology launches equity offering; shares down 16%</a></h4><ul><li>Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='red'>-15.9%</font>) <a href=\"https://seekingalpha.com/pr/16911987-kura-oncology-announces-commencement-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of 5.3M shares of common stock. Underwriters over-allotment is an additional 795K shares. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288274\" data-linked=\"Kura Oncology launches equity offering; shares down 16%\" data-tweet=\"$KURA - Kura Oncology launches equity offering; shares down 16% https://seekingalpha.com/news/3288274-kura-oncology-launches-equity-offering-shares-down-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3288274-kura-oncology-launches-equity-offering-shares-down-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288269\" data-ts=\"1502379853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTES\" target=\"_blank\">NTES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288269-neteaseminus-8_9-after-earnings-clsa-downgrades-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetEase -8.9% after earnings; CLSA downgrades to Sell</a></h4><ul>   <li>NetEase (NASDAQ:<a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc'>NTES</a>) is <font color='red'>8.9% lower</font> today after its <a href=\"https://seekingalpha.com/news/3287921-netease-minus-3-percent-profits-fall-short-despite-strong-revenue-growth\" target=\"_blank\">Q2 report</a> featured revenue growth of 47% and adjusted net income that grew 7.8% but missed consensus.</li>    <li>Gross profit grew in online games Y/Y but declined sequentially; meanwhile, e-commerce gross profit fell Y/Y as higher-margin businesses had a smaller revenue contribution.</li>    <li>On the <a href=\"https://seekingalpha.com/article/4097206-neteases-ntes-ceo-william-ding-q2-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">company's earnings call</a>, CEO William Ding noted \"Profitability is not a near-term focus\" on e-commerce, adding that \"our focus is still mainly to grow and market share; we want these two platforms (Kaola and Yanxuan) and our services and products to cover more families and users.\"</li>    <li>And CLSA downgraded shares to Underperform, pointing to a slowdown in online games (whose revenue fell 12% Q/Q) and e-commerce's drag on the company's margins. The stock's not cheap at a 21 P/E ratio, says analyst Man Ho Lam, who has a price target of $340 -- 7.9% upside from yesterday's close, and now 18.4% upside from today's lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288269\" data-linked=\"NetEase -8.9% after earnings; CLSA downgrades to Sell\" data-tweet=\"$NTES - NetEase -8.9% after earnings; CLSA downgrades to Sell https://seekingalpha.com/news/3288269-neteaseminus-8_9-after-earnings-clsa-downgrades-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3288269-neteaseminus-8_9-after-earnings-clsa-downgrades-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288263\" data-ts=\"1502378560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPP\" target=\"_blank\">PPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288263-primero-miningminus-40-production-cash-flow-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Primero Mining -40% as production, cash flow plunge</a></h4><ul>     <li>Primero Mining (<a href='https://seekingalpha.com/symbol/PPP' title='Primero Mining Corp. New Ordinary Shares'>PPP</a> <font color='red'>-40.9%</font>) plunges after reporting in-line <a href=\"https://seekingalpha.com/news/3288010-primero-mining-eps-line-misses-revenue\" target=\"_blank\">Q2 earnings</a> but a 62% Y/Y drop in revenues.</li>     <li>PPP says Q2 production totaled ~36K gold equiv. oz., down 27% from 49.5K gold equiv. oz. produced in the year-ago quarter; Q2 cash costs were $852 per gold equiv. oz. with all-in sustaining costs of $1,262 per gold oz.</li>     <li>Q2 production at the San Dimas mine in Mexico fell 55% Y/Y to 15,234 gold equiv. oz., hurt by a strike that was not resolved until April and a 13-day suspension of milling activities in June following the failure an anchor block affixed to a cable supporting the tailings pipeline suspension bridge.</li>     <li>PPP says it has received a number of proposals regarding a potential acquisition of San Dimas, but the proposals required a significant revision of the streaming agreement with Wheaton Precious Metals (<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a> <font color='green'>+0.6%</font>).</li>     <li>Operating cash flow before working capital changes fell to $8.4M from $11.2M at the end of the year-ago quarter.</li>     <li>PPP also agrees to sell its interest in the Black Fox mine in  Ontario to McEwen Mining (<a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='green'>+2%</font>) for $35M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288263\" data-linked=\"Primero Mining -40% as production, cash flow plunge\" data-tweet=\"$PPP $PPP $WPM - Primero Mining -40% as production, cash flow plunge https://seekingalpha.com/news/3288263-primero-miningminus-40-production-cash-flow-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3288263-primero-miningminus-40-production-cash-flow-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288262\" data-ts=\"1502378204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BW\" target=\"_blank\">BW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288262-babcock-wilcox-jumps-off-cliff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Babcock &amp; Wilcox jumps off a cliff</a></h4><ul><li>Babcock &amp; Wilcox Enterprises (<a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-61.9%</font>) has now <font color='red'>lost almost two thirds of its value</font> since yesterday's <a href=\"https://seekingalpha.com/news/3287738-babcock-and-wilcox-enterprises-eps-2_56\" target=\"_blank\">Q2 results</a>.</li><li>The stock is at a 52-week low at $3.77, down sharply from the $17 level at the beginning of 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288262\" data-linked=\"Babcock &amp; Wilcox jumps off a cliff\" data-tweet=\"$BW - Babcock &amp; Wilcox jumps off a cliff https://seekingalpha.com/news/3288262-babcock-wilcox-jumps-off-cliff?source=tweet\" data-url=\"https://seekingalpha.com/news/3288262-babcock-wilcox-jumps-off-cliff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288259\" data-ts=\"1502377935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288259-perrigo-divests-api-business-to-sk-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perrigo divests API business to SK Capital</a></h4><ul><li>Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='green'>+18.5%</font>) inks an <a href=\"https://seekingalpha.com/pr/16912973-sk-capital-announces-agreement-acquire-perrigo-company-plc-s-active-pharmaceutical\" target=\"_blank\">agreement </a>to sell its Active Pharmaceutical Ingredients &#40;API&#41; unit to private investment shop SK Capital for an undisclosed sum. The deal includes a long-term supply contract with Perrigo. The transaction should close by next quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288259\" data-linked=\"Perrigo divests API business to SK Capital\" data-tweet=\"$PRGO - Perrigo divests API business to SK Capital https://seekingalpha.com/news/3288259-perrigo-divests-api-business-to-sk-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3288259-perrigo-divests-api-business-to-sk-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288257\" data-ts=\"1502377767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDS\" target=\"_blank\">FDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288257-factsetminus-2_5-pacific-square-rings-alarm-bells\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FactSet -2.5% as Pacific Square rings alarm bells</a></h4><ul>   <li>FactSet Research Systems (NYSE:<a href='https://seekingalpha.com/symbol/FDS' title='FactSet Research Systems Inc.'>FDS</a>) is <font color='red'>off 2.5%</font> after coming into the sights of Pacific Square as a short case.</li>    <li>The firm noted margin pressures from higher costs for collection of data as well as pricing pressure from competitors as headwinds.</li>    <li>Most covering analysts are at Hold on the stock. Late last month, Stifel Nicolaus reiterated its Hold rating and a price target of $163; shares are $158.24 currently.</li>    <li>The company is expected to release its Q4 earnings Sept. 26; in June it <a href=\"https://seekingalpha.com/news/3275668-factset-beats-eps-estimates-guidance-beats-consensus\" target=\"_blank\">beat profit expectations</a> with its Q3 report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288257\" data-linked=\"FactSet -2.5% as Pacific Square rings alarm bells\" data-tweet=\"$FDS - FactSet -2.5% as Pacific Square rings alarm bells https://seekingalpha.com/news/3288257-factsetminus-2_5-pacific-square-rings-alarm-bells?source=tweet\" data-url=\"https://seekingalpha.com/news/3288257-factsetminus-2_5-pacific-square-rings-alarm-bells\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288249\" data-ts=\"1502377319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288249-biocept-banks-2_2m-private-capital-raise-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept banks $2.2M private capital raise; shares up 3%</a></h4><ul><li>Biocept (<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+2.9%</font>) inks an <a href=\"https://seekingalpha.com/pr/16912573-biocept-announces-private-placement-2_2-million-common-stock-ally-bridge-lb-healthcare-master\" target=\"_blank\">agreement </a>with institutional investor Ally Bridge LB Healthcare Master Fund Limited for the direct sale of 1,466,667 shares of common stock and warrants to purchase up to 1,434,639 shares of common at a combined price of $1.50.</li><li>The five-year warrants are immediately exercisable at $1.50 per common share.</li><li>Gross proceeds will be ~$2.2M. Closing date is today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288249\" data-linked=\"Biocept banks $2.2M private capital raise; shares up 3%\" data-tweet=\"$BIOC - Biocept banks $2.2M private capital raise; shares up 3% https://seekingalpha.com/news/3288249-biocept-banks-2_2m-private-capital-raise-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3288249-biocept-banks-2_2m-private-capital-raise-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288246\" data-ts=\"1502376834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288246-on-china-automitive-systems-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Automitive System&#39;s Q2</a></h4><ul>     <li>China Automotive Systems (<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a> <font color='green'>+2.2%</font>)&nbsp;reports net sales of traditional steering products grew by 32.8% in <a href=\"https://seekingalpha.com/pr/16912307-china-automotive-systems-reports-2017-second-quarter-unaudited-financial-results\" target=\"_blank\">Q2</a>.</li>     <li>Gross margin rate improved 160 bps to 20.4%, mainly due to a better revenue mix as total units sold to the international markets increased during the quarter.</li>     <li>Selling expense rate -20 bps to 3.9%.</li>     <li>Operating margin rate up 420 bps to 9.4%.</li>     <li>The company raised FY2017 revenue guidance to $490M.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3288246\" data-linked=\"More on China Automitive System&#39;s Q2\" data-tweet=\"$CAAS - More on China Automitive System&#39;s Q2 https://seekingalpha.com/news/3288246-on-china-automitive-systems-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3288246-on-china-automitive-systems-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288243\" data-ts=\"1502376656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288243-consumer-edge-warning-clips-dicks-sporting-goods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Edge warning clips Dick&#39;s Sporting Goods</a></h4><ul> <li>Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-7.3%</font>) swings lower after Consumer Edge lowers estimates ahead of next week's earnings report from the retailer.</li> <li>Another factor in today's trading on Dick's may be the solid apparel and footwear sales posted by Kohl's, according to Bloomberg.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3288243\" data-linked=\"Consumer Edge warning clips Dick&#39;s Sporting Goods\" data-tweet=\"$DKS - Consumer Edge warning clips Dick&#39;s Sporting Goods https://seekingalpha.com/news/3288243-consumer-edge-warning-clips-dicks-sporting-goods?source=tweet\" data-url=\"https://seekingalpha.com/news/3288243-consumer-edge-warning-clips-dicks-sporting-goods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288240\" data-ts=\"1502376129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288240-cb-and-i-plunges-31-to-eight-year-lows-following-disastrous-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I plunges 31% to eight-year lows following disastrous Q2 results</a></h4><ul>     <li>Chicago Bridge &amp;&nbsp;Iron (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-31.7%</font>) plunges to <a href=\"http://www.marketwatch.com/story/chicago-bridge-irons-stock-plunges-after-large-surprise-loss-slashed-outlook-2017-08-10\" target=\"_blank\">eight-year lows</a> at the open following yesterday's news of <a href=\"https://seekingalpha.com/news/3287807-cb-minus-22-percent-big-q2-loss-dividend-suspension\" target=\"_blank\">disastrous Q2 results</a> and a dividend suspension.</li>     <li>CBI also cut its FY 2017 guidance for EPS to $1.00-$1.25 from its earlier outlook for $3.50-$4.00 and for revenue to $3.7B-$4B from $9.5B-$10.5B.</li>     <li>Baird analysts maintain their Neutral rating on the stock and cut their price target to $10 from $24, seeing CBI's <a href=\"http://thefly.com/thestreet/realmoney/index.php/CBIid2594943/CBI-CBI-target-cut-to--cash-burn-puts-balance-sheet-back-in-focus-says-Baird\" target=\"_blank\">cash burn likely continuing</a> with ample risk stemming from further project degradation.</li>     <li>Citigroup also keeps its Neutral rating on CBI while trimming its price target to $18 from $20, as the firm <a href=\"http://thefly.com/thestreet/realmoney/index.php/CBIid2594718/CBI-Citi-cuts-CBI-target-doesnt-see-big-liquidity-risk\" target=\"_blank\">does not see a major liquidity risk</a> because the company's technology business is a \"significantly valuable asset that should have lots of interested buyers,\" but it worries that Q2's $548M in charges are \"more the start and not the end\" of CBIs challenges.</li>     <li>But Deutsche Bank <a href=\"http://thefly.com/thestreet/realmoney/index.php/CBIid2594984/CBI-Deutsche-Bank-lays-out-path-for-CBI-shares-getting-back-near-\" target=\"_blank\">maintains its Buy rating</a> although with a reduced target price of $21 from $25, seeing a \"clear path\" to trading near $20 again if management executes and avoid further cost overruns.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288240\" data-linked=\"CB&amp;I plunges 31% to eight-year lows following disastrous Q2 results\" data-tweet=\"$CBI - CB&amp;I plunges 31% to eight-year lows following disastrous Q2 results https://seekingalpha.com/news/3288240-cb-and-i-plunges-31-to-eight-year-lows-following-disastrous-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3288240-cb-and-i-plunges-31-to-eight-year-lows-following-disastrous-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288238\" data-ts=\"1502376044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288238-cb-and-i-loses-near-third-of-value\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I loses near a third of its value</a></h4><ul><li>Analysts are weighing in on Chicago Bridge (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-32.1%</font>) after it lost almost a third of its value since yesterday's <a href=\"https://seekingalpha.com/news/3287807-cb-minus-22-percent-big-q2-loss-dividend-suspension\" target=\"_blank\">Q2 results</a>.</li><li><strong>Baird:</strong> Kept CBI at Neutral, and reduced its PT to $10 from $24, stating a cash burn puts the company's balance sheet back in focus.</li><li><strong>Citibank:</strong> Also kept the stock at Neutral, and lowered its PT to $18 from $20, concerned that charges in Q2 are \"more the start\" of CB&amp;I's challenges.</li><li><strong>DA Davidson:</strong> Has a Buy rating on shares, saying weakness is \"overdone,\" but slashed the company's PT to $25 from $40, on the \"dismal\" results.</li><li><strong>Deutsche Bank:</strong> Maintained a Buy rating, but lowered its PT to $21 from $25, seeing shares rebounding should management avoid further cost overruns.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288238\" data-linked=\"CB&amp;I loses near a third of its value\" data-tweet=\"$CBI - CB&amp;I loses near a third of its value https://seekingalpha.com/news/3288238-cb-and-i-loses-near-third-of-value?source=tweet\" data-url=\"https://seekingalpha.com/news/3288238-cb-and-i-loses-near-third-of-value\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288237\" data-ts=\"1502375853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFR\" target=\"_blank\">SFR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288237-single-family-rental-sector-perky-after-starwood-invitation-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Single-family rental sector perky after Starwood/Invitation merger</a></h4><ul><li>Consolidation is the word in the single-family rental space, with Starwood Waypoint (<a href='https://seekingalpha.com/symbol/SFR' title='Starwood Waypoint Homes Inc'>SFR</a> <font color='green'>+5.4%</font>) and Invitation Homes (<a href='https://seekingalpha.com/symbol/INVH' title='Invitation Homes'>INVH</a> <font color='green'>+5%</font>) both sharply higher after their <a href=\"https://seekingalpha.com/news/3288157-single-family-scale-invitation-homes-starwood-waypoint-merge\" target=\"_blank\">merger-of-equals deal announcement</a>.</li><li>Other players in the rapidly converging sector: American Homes 4 Rent (<a href='https://seekingalpha.com/symbol/AMH' title='American Homes 4 Rent'>AMH</a> <font color='green'>+1.7%</font>) and Altisource Residential (<a href='https://seekingalpha.com/symbol/RESI' title='Front Yard Residential Corporation'>RESI</a> <font color='green'>+1.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3288237\" data-linked=\"Single-family rental sector perky after Starwood/Invitation merger\" data-tweet=\"$SFR $SFR $INVH - Single-family rental sector perky after Starwood/Invitation merger https://seekingalpha.com/news/3288237-single-family-rental-sector-perky-after-starwood-invitation-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3288237-single-family-rental-sector-perky-after-starwood-invitation-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288225\" data-ts=\"1502375458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288225-natural-gas-futures-spike-on-inventory-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural Gas futures spike on inventory data</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+28</strong> <strong>Bcf</strong> vs. +20 Bcf last week.</li><li>Futures&nbsp;<font color='green'>+0.35%</font>&nbsp;to $2.893.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>,<a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288225\" data-linked=\"Natural Gas futures spike on inventory data\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural Gas futures spike on inventory data https://seekingalpha.com/news/3288225-natural-gas-futures-spike-on-inventory-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3288225-natural-gas-futures-spike-on-inventory-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288219\" data-ts=\"1502375095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288219-vix-spikes-to-highest-since-mid-may\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VIX spikes to highest since mid-May</a></h4><ul><li>Sabre-rattling between the U.S. and North Korea has caused the most minor of shakes in the previously one-direction stock market, and it's got the left-for-dead VIX rising above 15 for the first time since May 18, according to Bloomberg.</li><li>A selection of ETFs: <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a>&nbsp;<font color='green'>+7.45%</font>, <a href='https://seekingalpha.com/symbol/XIV' title='VelocityShares Daily Inverse VIX Short-Term ETN'>XIV</a>&nbsp;<font color='red'>-7.55%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a>, <a href='https://seekingalpha.com/symbol/UVXY' title='ProShares Ultra VIX Short-Term Futures ETF'>UVXY</a>, <a href='https://seekingalpha.com/symbol/XIV' title='VelocityShares Daily Inverse VIX Short-Term ETN'>XIV</a>, <a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a>, <a href='https://seekingalpha.com/symbol/SVXY' title='ProShares Short VIX Short-Term Futures ETF'>SVXY</a>, <a href='https://seekingalpha.com/symbol/VIXY' title='ProShares VIX Short-Term Futures ETF'>VIXY</a>, <a href='https://seekingalpha.com/symbol/VMAX' title='REX VolMAXX Long VIX Weekly Futures Strategy ETF'>VMAX</a>, <a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>, <a href='https://seekingalpha.com/symbol/VMIN' title='REX VolMAXX Inverse VIX Weekly Futures Strategy ETF'>VMIN</a>, <a href='https://seekingalpha.com/symbol/XXV' title='iPath Inverse S&P 500 VIX Short-Term Futures ETN'>XXV</a>, <a href='https://seekingalpha.com/symbol/IVOP' title='iPath Inverse S&P 500 VIX Short-Term Futures ETN'>IVOP</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288219\" data-linked=\"VIX spikes to highest since mid-May\" data-tweet=\"$VXX $XIV $UVXY - VIX spikes to highest since mid-May https://seekingalpha.com/news/3288219-vix-spikes-to-highest-since-mid-may?source=tweet\" data-url=\"https://seekingalpha.com/news/3288219-vix-spikes-to-highest-since-mid-may\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288217\" data-ts=\"1502375057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIN\" target=\"_blank\">DIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288217-dineequity-higher-after-earnings-beat-ceo-chairman-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DineEquity higher after earnings beat, CEO/chairman split</a></h4><ul> <li>DineEquity (<a href='https://seekingalpha.com/symbol/DIN' title='Dine Brands Global, Inc.'>DIN</a> <font color='green'>+12.6%</font>) trades higher after topping Q2 estimates as comparable sales drops for the IHOP and Applebee's chains came in slightly better than anticipated. The restaurant operators also backed its prior full-year guidance.</li> <li>Perhaps the even bigger news out of DineEquity is that it's splitting the CEO and chairman roles. The company hired Choice Hotels's Stephen Joyce for the CEO position, while Richard Dahl stays on as chairman.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3288070-dineequity-beats-0_13-revenue-line\" target=\"_blank\">DineEquity beats by $0.13,  revenue in-line</a> (Aug. 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288217\" data-linked=\"DineEquity higher after earnings beat, CEO/chairman split\" data-tweet=\"$DIN - DineEquity higher after earnings beat, CEO/chairman split https://seekingalpha.com/news/3288217-dineequity-higher-after-earnings-beat-ceo-chairman-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3288217-dineequity-higher-after-earnings-beat-ceo-chairman-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288209\" data-ts=\"1502374671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288209-invivo-down-27-on-issuance-of-2m-shares-of-stock-to-warrant-holders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo down 27% on issuance of 2M shares of stock to warrant holders</a></h4><ul><li>InVivo Therapeutics (<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-27.1%</font>) slumps on almost double normal volume in response to its <a href=\"https://seekingalpha.com/pr/16912765-invivo-therapeutics-announces-exchange-certain-warrants-common-stock\" target=\"_blank\">announcement </a>that it issued 2,021,419 new shares of common stock for the majority of existing 2014 Warrants as specified in the anti-dilution clause.</li><li>Putting a positive spin on the significant haircut to shareholders, CEO Mark Perrin says,&nbsp;&ldquo;We believe that these exchange agreements benefit our shareholders and the company by creating a substantially cleaner balance sheet for the company and removing a significant financial overhang. This puts us in a much stronger financial position as we work toward reopening enrollment in The INSPIRE Study and delivering on our mission for spinal cord injury patients.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3288209\" data-linked=\"InVivo down 27% on issuance of 2M shares of stock to warrant holders\" data-tweet=\"$NVIV - InVivo down 27% on issuance of 2M shares of stock to warrant holders https://seekingalpha.com/news/3288209-invivo-down-27-on-issuance-of-2m-shares-of-stock-to-warrant-holders?source=tweet\" data-url=\"https://seekingalpha.com/news/3288209-invivo-down-27-on-issuance-of-2m-shares-of-stock-to-warrant-holders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288201\" data-ts=\"1502373894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288201-wainwright-ups-price-target-on-biodelivery-to-5-on-improved-outlook-for-belbuca-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wainwright ups price target on BioDelivery to $5 on improved outlook for Belbuca; shares down 8% after Q2 results</a></h4><ul><li>BioDelivery Sciences (<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color='red'>-7.9%</font>) price target raised to $5 from $4 by H.C. Wainwright citing an 20% increase in Belbuca sales estimate for 2017/2018.</li><li>Shares are under pressure following Q2 results. Loss/share was ($0.03) wider than consensus while revenue beat slightly.</li><li>Belbuca sales were $4.6M, up 43.5%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288201\" data-linked=\"Wainwright ups price target on BioDelivery to $5 on improved outlook for Belbuca; shares down 8% after Q2 results\" data-tweet=\"$BDSI - Wainwright ups price target on BioDelivery to $5 on improved outlook for Belbuca; shares down 8% after Q2 results https://seekingalpha.com/news/3288201-wainwright-ups-price-target-on-biodelivery-to-5-on-improved-outlook-for-belbuca-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3288201-wainwright-ups-price-target-on-biodelivery-to-5-on-improved-outlook-for-belbuca-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288196\" data-ts=\"1502373269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMD\" target=\"_blank\">CRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288196-r-and-r-trims-price-targets-for-cormedix-and-synergy-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">R&amp;R trims price targets for Cormedix and Synergy Pharma</a></h4><ul><li>Cormedix (<a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color='green'>+4.2%</font>) price target lowered to $3 from $5 by Rodman &amp; Renshaw citing recent dilution and the expectation of further financing.</li><li>Synergy Pharmaceuticals (<a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='red'>-13.3%</font>) price target lowered to $15 from $18 by Rodman &amp; Renshaw after Q2 results.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3288196\" data-linked=\"R&amp;R trims price targets for Cormedix and Synergy Pharma\" data-tweet=\"$CRMD $CRMD $SGYP-OLD - R&amp;R trims price targets for Cormedix and Synergy Pharma https://seekingalpha.com/news/3288196-r-and-r-trims-price-targets-for-cormedix-and-synergy-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3288196-r-and-r-trims-price-targets-for-cormedix-and-synergy-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288192\" data-ts=\"1502372873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288192-blue-apronminus-16-confidence-fades-bye-bye-hellofresh-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron -16% as confidence fades, bye-bye HelloFresh IPO?</a></h4><ul> <li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) plunges on the open after execs warn on the earnings conference call about unexpected costs related to setting up a new manufacturing facility.</li> <li>The company's management also said that labor wage pressure is a factor for its bottom line.</li> <li>Shares are <font color='red'>down 16.35%</font> to $5.19 and traded as low as $5.03. Across the pond in Frankfurt, shares of HelloFresh owner Rocket Internet are <font color='red'>down 1.45%</font>. Hopes for a HelloFresh IPO may be fading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288046-blue-apron-misses-0_17-beats-revenue\" target=\"_blank\">Blue Apron misses by $0.17, beats on revenue</a> (Aug. 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288056-blue-apron-reports-loss-first-post-ipo-report\" target=\"_blank\">Blue Apron reports loss in first post-IPO report</a> (Aug. 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288192\" data-linked=\"Blue Apron -16% as confidence fades, bye-bye HelloFresh IPO?\" data-tweet=\"$APRN - Blue Apron -16% as confidence fades, bye-bye HelloFresh IPO? https://seekingalpha.com/news/3288192-blue-apronminus-16-confidence-fades-bye-bye-hellofresh-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3288192-blue-apronminus-16-confidence-fades-bye-bye-hellofresh-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288180\" data-ts=\"1502371542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYV\" target=\"_blank\">LYV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288180-solid-earnings-beat-drives-live-nationplus-8_5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid earnings beat drives Live Nation +8.5% premarket</a></h4><ul>   <li>Live Nation Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/LYV' title='Live Nation Entertainment, Inc.'>LYV</a>) is <font color='green'>up 8.5%</font> in premarket trading after it easily surpassed expectations with its <a href=\"https://seekingalpha.com/news/3287778-live-nation-entertainment-beats-0_10-beats-revenue\" target=\"_blank\">Q2 earnings report</a>.</li>    <li>Revenue rose 29% and adjusted operating income was up 22%, to $221M.</li>    <li>The company rode its concerts business to the win; it's sold 68M tickets to events this year through July, 12M tickets ahead of last year's pace.</li>    <li>Revenue breakout: Concerts, $2.25B (up 34%); Sponsorship and Advertising, $124.6M (up 31%); Ticketing, $484.6M (up 9%); other, -$40.4M.</li>    <li>Operating income breakout: Concerts, $37.5M (up from $2.8M); Sponsorship and Advertising, $70.4M (up 19%); Ticketing, $43.7M (down 6%); other, -$5.2M.</li>    <li>Cash from operations rose to $43M and free cash flow grew 42%, to $154M.</li>    <li>It expected 2017 to bring more record results in revenue and operating income, with key indicators (concert tickets sold, contracted sponsorship, and fee-bearing ticketing GTV) pointing up double digits.</li>    <li><a href=\"https://seekingalpha.com/pr/16912001-live-nation-entertainment-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3288180\" data-linked=\"Solid earnings beat drives Live Nation +8.5% premarket\" data-tweet=\"$LYV - Solid earnings beat drives Live Nation +8.5% premarket https://seekingalpha.com/news/3288180-solid-earnings-beat-drives-live-nationplus-8_5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3288180-solid-earnings-beat-drives-live-nationplus-8_5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288179\" data-ts=\"1502371464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288179-sangamo-up-7-after-q2-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo up 7% after Q2 beat</a></h4><ul><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) is up&nbsp;<font color='green'>7%&nbsp;</font>premarket on light volume after releasing Q2 results that beat consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287705-sangamo-therapeutics-beats-0_02-beats-revenue\" target=\"_blank\">Sangamo Therapeutics beats by $0.02, beats on revenue</a> (Aug. 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287797-sangamo-q2-loss-narrows-data-four-trials-tap-h1-2018\" target=\"_blank\">Sangamo Q2 loss narrows; data from four trials on tap in H1 2018</a> (Aug. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288179\" data-linked=\"Sangamo up 7% after Q2 beat\" data-tweet=\"$SGMO - Sangamo up 7% after Q2 beat https://seekingalpha.com/news/3288179-sangamo-up-7-after-q2-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3288179-sangamo-up-7-after-q2-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288174\" data-ts=\"1502371236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288174-portola-down-7-premarket-on-q2-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola down 7% premarket on Q2 miss</a></h4><ul><li>Portola Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a>) slips&nbsp;<font color='red'>7%</font>&nbsp;premarket on modest volume after its posted Q2 results that fell shy of consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287779-portola-pharmaceuticals-misses-0_24-misses-revenue\" target=\"_blank\">Portola Pharmaceuticals misses by $0.24, misses on revenue</a> (Aug. 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287811-portola-q2-loss-widens-u-s-bevyxxa-launch-deck\" target=\"_blank\">Portola Q2 loss widens; U.S. Bevyxxa launch on deck</a> (Aug. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288174\" data-linked=\"Portola down 7% premarket on Q2 miss\" data-tweet=\"$PTLA - Portola down 7% premarket on Q2 miss https://seekingalpha.com/news/3288174-portola-down-7-premarket-on-q2-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3288174-portola-down-7-premarket-on-q2-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288168\" data-ts=\"1502371050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALQA\" target=\"_blank\">ALQA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288168-alliqua-bio-q2-revenue-up-24-shares-ahead-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliqua Bio Q2 revenue up 24%, shares ahead 3% premarket</a></h4><ul><li>Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <a href=\"https://seekingalpha.com/pr/16912397-alliqua-biomedical-inc-reports-second-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Q2 results</a>: Revenue: $5.5M (+23.6%); Product Sales: $4.9M (+34.4%).</li><li>Biologic product sales up 106%, UltraMist sales up 147%.</li><li><strong>2017 Guidance</strong>: Product sales: $19.0M - 19.9M; Contract manufacturing sales: $1.4M, down 36% from last year's $2.2M due to loss of a customer.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288168\" data-linked=\"Alliqua Bio Q2 revenue up 24%, shares ahead 3% premarket\" data-tweet=\"$ALQA $ADYX - Alliqua Bio Q2 revenue up 24%, shares ahead 3% premarket https://seekingalpha.com/news/3288168-alliqua-bio-q2-revenue-up-24-shares-ahead-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3288168-alliqua-bio-q2-revenue-up-24-shares-ahead-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288167\" data-ts=\"1502371038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288167-yy-up-2_6-rapid-live-streaming-growth-drives-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY up 2.6% as rapid live streaming growth drives earnings beat</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color='green'>up 2.6%</font> premarket on <a href=\"https://seekingalpha.com/news/3287979-yy-beats-0_28-beats-revenue\" target=\"_blank\">Q2 results</a> where its core live streaming drove revenues up nearly 32%.</li>    <li>Adjusted net income rose 55%, to 597.2M yuan (about $88.1M).</li>    <li>Net margin rose to 22.9% from a year-ago 19.4% due to increasing operating leverage and product cost and expense controls.</li>    <li>Live streaming monthly active users were up 27% to more than 66.1M, and live streaming paying users rose 46.1% to more than 5.7M.</li>    <li>Revenue by segment: Live streaming, 2.373B yuan ($350.1M, up 42.9% in renminbi terms); Online games, 154M yuan ($22.7M, down 18.2%); Membership, 52.2M yuan ($7.7M, down 27.6%); others, 29.4M yuan ($4.3M, down 50.4%).</li>    <li>Cash and equivalents came to 1.349B yuan (about $199M), along with short-term deposits of 1.89B yuan ($278.8M) and restricted short-term deposits of 1B yuan ($147.5M). Net cash from operations for the quarter was 885.6M yuan ($130.6M).</li>    <li>For Q3, it's guiding to revenue growth of 31.6%-36.4% -- to between 2.75B yuan and 2.85B yuan ($413.3M-$428.3M).</li>    <li><a href=\"https://seekingalpha.com/pr/16912323-yy-reports-second-quarter-2017-unaudited-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3288167\" data-linked=\"YY up 2.6% as rapid live streaming growth drives earnings beat\" data-tweet=\"$YY - YY up 2.6% as rapid live streaming growth drives earnings beat https://seekingalpha.com/news/3288167-yy-up-2_6-rapid-live-streaming-growth-drives-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3288167-yy-up-2_6-rapid-live-streaming-growth-drives-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288166\" data-ts=\"1502371023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288166-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a>&nbsp;<font color='red'>-22%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3287747-chicago-bridge-and-iron-misses-3_85-misses-revenue\" target=\"_blank\">Q2 earnings</a>&nbsp;miss.</li><li><a href='https://seekingalpha.com/symbol/NSU' title='Nevsun Resources Ltd.'>NSU</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3287870-nevsun-resources-misses-0_14-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3287873-xtant-medical-misses-0_32-misses-revenue\" target=\"_blank\">Q2 earnings</a>&nbsp;miss.</li><li><a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3288046-blue-apron-misses-0_17-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3288051-dillards-eps-0_58\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3287779-portola-pharmaceuticals-misses-0_24-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3288006-dynavax-prices-stock-offering-15-shares-7-percent-premarket\" target=\"_blank\">pricing</a> stock offering.</li><li><a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc'>NTES</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3287925-netease-beats-0_04-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3288148-modine-manufacturing-launch-5m-share-offering\" target=\"_blank\">announcing</a> public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/MX' title='MagnaChip Semiconductor Corporation'>MX</a> <font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16911931-magnachip-discloses-commencement-secondary-offering-selling-stockholders-4088-978-shares\" target=\"_blank\">commencement</a> of secondary offering of common stock..</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3288166\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$CBI $NSU $XTNT - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3288166-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3288166-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288156\" data-ts=\"1502370366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288156-xtant-q2-miss-pressures-shares-down-15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xtant Q2 miss pressures shares, down 15% premarket</a></h4><ul><li>Nano cap Xtant Medical Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a>) slips&nbsp;<font color='red'>15%</font>&nbsp;premarket on average volume after it released <a href=\"https://seekingalpha.com/pr/16912130-xtant-medical-reports-second-quarter-2017-financial-results\" target=\"_blank\">Q2 results</a> that fell short of consensus.</li><li>Revenue: $21.4M (-0.5%); Loss/Share: ($0.54) (-45.9%).</li><li>Cash on hand as of June 30 was only $1.7M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287873-xtant-medical-misses-0_32-misses-revenue\" target=\"_blank\">Xtant Medical misses by $0.32, misses on revenue</a> (Aug. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3288156\" data-linked=\"Xtant Q2 miss pressures shares, down 15% premarket\" data-tweet=\"$XTNT - Xtant Q2 miss pressures shares, down 15% premarket https://seekingalpha.com/news/3288156-xtant-q2-miss-pressures-shares-down-15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3288156-xtant-q2-miss-pressures-shares-down-15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288149\" data-ts=\"1502370173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UN\" target=\"_blank\">UN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288149-rbc-capital-warns-on-unilever\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC Capital warns on Unilever</a></h4><ul> <li>RBC Capital lowers Unilever (<a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a>, <a href='https://seekingalpha.com/symbol/UL' title='Unilever Plc'>UL</a>) to an Underperform rating after having the consumer products giant set at Sector Perform.</li> <li>The investment firm warns that Unilever's goal to hit 20% operating margins by 2020 may be a reach and notes the recent run-up in share price may be setting up investors for a disappointment.</li> <li>Shares of Unilever are <font color='red'>down 1.44%</font> premarket to $56.82.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288149\" data-linked=\"RBC Capital warns on Unilever\" data-tweet=\"$UN $UN $UL - RBC Capital warns on Unilever https://seekingalpha.com/news/3288149-rbc-capital-warns-on-unilever?source=tweet\" data-url=\"https://seekingalpha.com/news/3288149-rbc-capital-warns-on-unilever\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288148\" data-ts=\"1502370172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOD\" target=\"_blank\">MOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288148-modine-manufacturing-to-launch-5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Modine Manufacturing to launch 5M-share offering</a></h4><ul>     <li>Modine Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a>) <font color='red'>-8.3%</font> premarket after commencing a 5M-share <a href=\"https://seekingalpha.com/pr/16911920-modine-announces-public-offering-common-stock\" target=\"_blank\">public offering</a>, with an underwriters option to purchase up to an additional 750K common shares.</li>     <li>MOD plans to use the proceeds to pay down outstanding indebtedness.</li>     <li><strong>Update</strong>:&nbsp;MOD says it is <a href=\"https://seekingalpha.com/pr/16912827-modine-announces-termination-public-offering-common-stock\" target=\"_blank\">terminating the offering</a>, deciding that \"current equity market conditions are not conducive for an offering on terms that would be in the best interests of the company's shareholders.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288148\" data-linked=\"Modine Manufacturing to launch 5M-share offering\" data-tweet=\"$MOD - Modine Manufacturing to launch 5M-share offering https://seekingalpha.com/news/3288148-modine-manufacturing-to-launch-5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3288148-modine-manufacturing-to-launch-5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288137\" data-ts=\"1502369867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONVO\" target=\"_blank\">ONVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288137-organovo-confirms-fiscal-2018-outlook-shares-up-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Organovo confirms fiscal 2018 outlook; shares up 8% premarket</a></h4><ul><li>Organovo Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a>) is up&nbsp;<font color='green'>8%&nbsp;</font>premarket after it posted fiscal Q1 results and <a href=\"https://seekingalpha.com/pr/16911909-organovo-announces-fiscal-first-quarter-2018-results-company-affirms-full-year-fiscal-2018\" target=\"_blank\">affirmed </a>its fiscal year outlook.</li><li>Revenue was $990K for the quarter, up 11%.</li><li>70% of orders for tissue research services came from existing customers.</li><li>Bioprinted liver tissues surviving 90 days post-implant in animal models.</li><li><strong>Fiscal 2018 Guidance</strong>: Revenue: $6.0M - 8.5M; Non-GAAP EBITDA: ($31M - 29M).</li></ul><div class=\"tiny-share-widget\" data-id=\"3288137\" data-linked=\"Organovo confirms fiscal 2018 outlook; shares up 8% premarket\" data-tweet=\"$ONVO - Organovo confirms fiscal 2018 outlook; shares up 8% premarket https://seekingalpha.com/news/3288137-organovo-confirms-fiscal-2018-outlook-shares-up-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3288137-organovo-confirms-fiscal-2018-outlook-shares-up-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288125\" data-ts=\"1502369111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288125-tg-therapeutics-drops-single-agent-tgrminus-1202-in-mid-stage-blood-cancer-study-due-to-lack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG Therapeutics drops single-agent TGR-1202 in mid-stage blood cancer study due to lack of efficacy, continues with U2 + Benda on significant treatment effect; shares slip 1% premarket</a></h4><ul><li>TG Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a>) eases&nbsp;<font color='red'>1%</font>&nbsp;premarket, albeit on only 700 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/16912443-tg-therapeutics-inc-announces-successful-outcome-first-pre-planned-interim-analysis\" target=\"_blank\">announcement</a> of results from a pre-planned interim analysis of its Phase 2b clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02793583?term=tg+therapeutics&amp;titles=unity-nhl&amp;rank=1\" target=\"_blank\">UNITY-NHL</a>, assessing single-agent TGR-1202 and the triple combination of TG-1101 + TG-1202 + bendamustine in patients with treatment-resistant diffuse large B-cell lymphoma &#40;DLBCL&#41; who are ineligible for high-dose chemo or transplant.</li><li>The independent Data and Safety Monitoring Board &#40;DSMB&#41; recommended the termination of enrollment in the single-agent TGR-1202 arm due to lack of efficacy and to continue with the triplet therapy arm, called U2 + Benda.</li><li>Relapsed DLBCL patients receiving U2 + Benda showed a 100% response rate while half of the refractory DLBCL patients responded. It will be evaluated in the next phase of the trial.</li><li>UNITY-NHL is a Phase 2/3 study that should be completed in mid-2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3288125\" data-linked=\"TG Therapeutics drops single-agent TGR-1202 in mid-stage blood cancer study due to lack of efficacy, continues with U2 + Benda on significant treatment effect; shares slip 1% premarket\" data-tweet=\"$TGTX - TG Therapeutics drops single-agent TGR-1202 in mid-stage blood cancer study due to lack of efficacy, continues with U2 + Benda on significant treatment effect; shares slip 1% premarket https://seekingalpha.com/news/3288125-tg-therapeutics-drops-single-agent-tgrminus-1202-in-mid-stage-blood-cancer-study-due-to-lack?source=tweet\" data-url=\"https://seekingalpha.com/news/3288125-tg-therapeutics-drops-single-agent-tgrminus-1202-in-mid-stage-blood-cancer-study-due-to-lack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288105\" data-ts=\"1502368034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDS\" target=\"_blank\">DDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288105-markdowns-lead-dillards-to-surprise-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Markdowns lead Dillard&#39;s to surprise loss</a></h4><ul> <li>Shares of Dillard's (NYSE:<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>) fall sharply after the department store chain posts a surprise <a href=\"https://seekingalpha.com/pr/16912432-dillard-s-inc-reports-second-quarter-results\" target=\"_blank\">Q2</a> loss.</li> <li>\"Significant markdowns led to a disappointing loss as we dealt with inventory, which was up 2% at quarter end,\" laments CEO William Dillard.</li> <li>Margin rates plunged during the quarter due to the markdown action.</li> <li>Total sales fell 1.7% to $1.427B. Comparable sales were down 1%, dragged down by a weak performance in shoes, cosmetics and home furniture.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288051-dillards-eps-0_58\" target=\"_blank\">Dillard's EPS of -$0.58</a> (Aug. 10)</li> <li>DDS <font color='red'>-15.61%</font> premarket to $61.89.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288105\" data-linked=\"Markdowns lead Dillard&#39;s to surprise loss\" data-tweet=\"$DDS - Markdowns lead Dillard&#39;s to surprise loss https://seekingalpha.com/news/3288105-markdowns-lead-dillards-to-surprise-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3288105-markdowns-lead-dillards-to-surprise-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288096\" data-ts=\"1502367466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAC\" target=\"_blank\">AAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288096-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>AAC Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) initiated with Overweight rating and $11 (34% upside)&nbsp;price target by Cantor Fitzgerald.</li><li>BioScrip (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a>) upgraded to Buy with a $3.75 (30% upside)&nbsp;price target by SunTrust.</li><li>Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) upgraded to Equal Weight with a $62 (flat) price target by Morgan Stanley.</li><li>Syros Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals'>SYRS</a>) downgraded to Market Perform by JMP Securities.</li><li>Achillion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a>) downgraded to Neutral with a $5 (4% upside)&nbsp;price target by Baird citing doubts that PNH candidate ACH-4471 can compete with Alexion's Soliris.</li><li>Athersys (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a>) price target raised to $12 (875% upside)&nbsp;from $9 by Maxim Group after Q2 beat.</li><li>Agios Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a>) price target raised to $72 (19% upside) from $54 citing recent approval of commercialization partner Celgene's IDHIFA (enasidenib) and plans for a Phase 3 study of AG-348 in adults with pyruvate kinase deficiency &#40;PKD&#41;.</li><li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) price target raised to $17.50 (39% upside) from $12.50 by Chardan Capital citing Galafold progress in Fabry disease and positive data on ATB200/AT2221 in Pompe disease.</li><li>Aralez Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a>) price target lowered to $4 (257% upside)&nbsp;from $5.50 by Chardan after Q2 results.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3288096\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$AAC $AAC $BIOS - Premarket analyst action - healthcare https://seekingalpha.com/news/3288096-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3288096-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288094\" data-ts=\"1502367443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288094-comparable-sales-fall-again-macys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales fall again at Macy&#39;s</a></h4><ul> <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) reports owned plus licensed comparable sales fell 2.5% in <a href=\"https://seekingalpha.com/pr/16912556-macy-s-inc-reports-second-quarter-earnings-reaffirms-full-year-guidance\" target=\"_blank\">Q2</a> to top the consensus estimate for a 3.0% drop.</li> <li>Gross margin came in at 40.3% of sales during the period vs. 39.9% consensus.</li> <li>\"We saw a notable contribution from the full execution of our new women's shoe and jewelry models and the continued successful testing of Backstage in store,\" says CEO Jeff Gennette.</li> <li>The department store operator backs prior guidance for sales to fall 3.2% to 4.3% this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288071-macys-beats-0_02-beats-revenue\" target=\"_blank\">Macy's beats by $0.02, beats on revenue</a> (Aug. 10)</li> <li>Shares of Macy's are <font color='red'>down 0.83%</font> in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288094\" data-linked=\"Comparable sales fall again at Macy&#39;s\" data-tweet=\"$M - Comparable sales fall again at Macy&#39;s https://seekingalpha.com/news/3288094-comparable-sales-fall-again-macys?source=tweet\" data-url=\"https://seekingalpha.com/news/3288094-comparable-sales-fall-again-macys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288091\" data-ts=\"1502367312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RADA\" target=\"_blank\">RADA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288091-rada-electronics-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rada Electronics reports Q2 results</a></h4><ul><li>Rada Electronics (NASDAQ:<a href='https://seekingalpha.com/symbol/RADA' title='Rada Electronics Industries Limited'>RADA</a>): Q2 EPS of $0.02</li><li>Revenue of $5.32M (+94.9% Y/Y)</li><li>Shares <font color='green'>+8.76%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16912579-rada-electronic-industries-announces-q2-2017-results-improvements-across-parameters'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288091\" data-linked=\"Rada Electronics reports Q2 results\" data-tweet=\"$RADA - Rada Electronics reports Q2 results https://seekingalpha.com/news/3288091-rada-electronics-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3288091-rada-electronics-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288082\" data-ts=\"1502366948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAT\" target=\"_blank\">EAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288082-sales-guidance-from-brinker-international-tops-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sales guidance from Brinker International tops expectations</a></h4><ul>     <li>Brinker International (NYSE:<a href='https://seekingalpha.com/symbol/EAT' title='Brinker International, Inc.'>EAT</a>) reports comparables sales fell 1.8% in <a href=\"https://seekingalpha.com/pr/16912344-brinker-international-reports-fourth-quarter-fiscal-year-results\" target=\"_blank\">FQ4</a>&nbsp;to edge past the consensus estimate.</li><li>Comparable sales fell 2.2% at company-owned Chili's restaurants on a 6.5% drop in traffic, while increasing 0.5% at Maggiano's locations. Both chains saw a positive impact from pricing during the quarter.</li>          <li>Restaurant-level operating margin fell 130 bps to 17.0% of sales during the quarter.</li>   <li>Looking ahead, Brinker sees FY18 revenue of $3.27B to $3.30B vs. $3.17B consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288001-brinker-beats-0_05-beats-revenue\" target=\"_blank\">Brinker beats by $0.05, beats on revenue</a> (Aug. 10)</li>     <li>EAT <font color='green'>+3.59%</font> premarket to $35.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3288082\" data-linked=\"Sales guidance from Brinker International tops expectations\" data-tweet=\"$EAT - Sales guidance from Brinker International tops expectations https://seekingalpha.com/news/3288082-sales-guidance-from-brinker-international-tops-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3288082-sales-guidance-from-brinker-international-tops-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288071\" data-ts=\"1502366539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288071-macys-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s beats by $0.02, beats on revenue</a></h4><ul><li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>): Q2 EPS of $0.48 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $5.55B (-5.5% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+5.7%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16912556-macy-s-inc-reports-second-quarter-earnings-reaffirms-full-year-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3288071\" data-linked=\"Macy&#39;s beats by $0.02, beats on revenue\" data-tweet=\"$M - Macy&#39;s beats by $0.02, beats on revenue https://seekingalpha.com/news/3288071-macys-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3288071-macys-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3288065\" data-ts=\"1502366348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAM\" target=\"_blank\">BAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3288065-brookfield-asset-managementplus-2_6-after-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookfield Asset Management +2.6% after Q2 results</a></h4><ul><li>Q2 FFO of $1.026B or $1.01 per share vs. $637M and $0.62 a year ago. Excluding realized disposition gains, FFO from operating activities of $562M was up 9% from $514M a year ago. Those disposition gains were helped by the sale of the company's interest in 245 Park Avenue, resulting in a $464M gain.</li><li>Fee-related earnings up 22% Y/Y thanks to higher fee-bearing assets and higher incentive distributions. Invested capital FFO up 2%.</li><li>Quarterly dividend continues at $0.14 per share.</li><li>$9B put to work during quarter. Fundraising currently underway for the next flagship real estate fund which is expected to be larger than its predecessor.</li><li><a href=\"http://www.brookfield.com\" target=\"_blank\">Conference call at 11 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3288028-brookfield-asset-management-beats-0_45-beats-revenue\" target=\"_blank\">Brookfield Asset Management beats by $0.45, beats on revenue</a> (Aug. 10)</li><li><a href='https://seekingalpha.com/symbol/BAM' title='Brookfield Asset Management Inc.'>BAM</a>&nbsp;<font color='green'>+2.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3288065\" data-linked=\"Brookfield Asset Management +2.6% after Q2 results\" data-tweet=\"$BAM - Brookfield Asset Management +2.6% after Q2 results https://seekingalpha.com/news/3288065-brookfield-asset-managementplus-2_6-after-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3288065-brookfield-asset-managementplus-2_6-after-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}